The scientists discovered that a drug that thwarts the production of fatty acids can block the spread of leukemia without damaging the brain cells.
The results from the study constitute a historical breakthrough after twenty years for the 160,000 patients across the world suffering from this common form of leukemia.
Lead researcher Dr. Yaron Carmi believes that the treatment will be available within two years for human trials and compassionate use.
During pivotal trials that led to the drug's approval, approximately 40% of patients saw their tumors shrink in size.
The significance of the findings is an important step towards eliminating cancer-causing cells and preventing recurrence in patients who have allegedly recovered.
Acute leukemia is a malignant disease that develops very quickly. Without proper treatment, patients can reach a life-threatening condition within days of diagnosis.